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Plants of the genus Gelsemium have mea-
surable effects on anxiety-like symptoms
in laboratory models (Magnani et al.,
2010; Liu et al., 2013; Meyer et al., 2013;
Jin et al., 2014). Searching for a possi-
ble mechanism of action, we found that
very low doses and homeopathic dilutions
of Gelsemium sempervirens (Gelsemium)
modulate the expression of genes involved
in neuronal functions (G-protein cou-
pled receptor signaling pathways, calcium
homeostasis, inflammatory response and
receptors) (Marzotto et al., 2014; Olioso
et al., 2014).
The commentary’s first criticism is that
“the search for an involvement of neu-
ral genes related to anxiety/depression
or mood disorders is biased by the
expression of human genes having no
orthologs/homologs in mice, where
the authors reported evidence about
Gelsemium action on behavioral tests in
animal anxiety models.” Frankly, we do
not see what type of bias can be found
in our line of research: Gelsemium is
traditionally used as a remedy for anxiety-
related symptoms in humans; we have
shown that it works in mice models
(Magnani et al., 2010; Bellavite et al.,
2012), and we wanted to study its mech-
anism of action at the molecular level,
using human neurocyte cell lines. This
type of experimental procedure, which
addresses various knowledge gaps using
both animal studies and in vitro models, is
very common in pharmacological studies.
Furthermore, the commentary
(Chirumbolo, 2014) states that “some
genes indicated to be downregulated by
Gelsemium 2c, should not be expressed by
neuronal cells (e.g., CD163, MPO, C8B,
LST1, TREM2, notoriously expressed in
immune cell).” Actually, it is well known
that neurons express genes of cellular path-
ways also involved in cytokine/chemokine
and immune responses. Genes related to
immune and inflammatory responses are
expressed in SH-SY5Y cells, as reported
by many researchers (Gatta et al., 2011;
Toyama et al., 2011; Cui et al., 2012; Xu
et al., 2013).
Although Gelsemium contains several
different compounds (Dutt et al., 2010;
Jin et al., 2014), the major active alka-
loid of this plant is gelsemine. In the
cited commentary we read that “concen-
tration of gelsemine was not assessed, as
it was solely calculated on previous spec-
trometry investigations and new prepara-
tions, from ethanol draw extracts, were
not further quantified by analytical chem-
istry.” This statement ismisleading because
the concentration of gelsemine which we
correctly reported (0.021 g/100ml, corre-
sponding to 6.5× 10−4 mol/L) (Marzotto
et al., 2014, p. 2) was precisely deter-
mined by liquid chromatography (not
“spectrometry”) in the mother tincture
from which the samples were prepared.
The concentration of UV-VIS absorb-
ing substances decreased by a factor of
100 at each centesimal dilution step,
to become analytically undetectable after
a few passages, as we have shown by
means of spectrometry in our paper. What
we were interested in was to check the
accuracy of the procedures as far as pos-
sible, not to determine the gelsemine con-
centration in all subsequent centesimal
dilutions. Perhaps we need to remind read-
ers that normally, when one performs a
study of dose-response and the concentra-
tion in the highest dose and the dilution
factor are known, there is no need to deter-
mine the concentration of substances in all
successive dilutions.
Another erroneous criticism which
forces us to reply is the statement
(Chirumbolo, 2014) that our UV-VIS
spectra (Marzotto et al., 2014) “showed
a peak at 250 nm caused by contaminat-
ing millimolar ethanol in Gelsemium 2c.”
This is untrue, and we fail to understand
how the writer could have reached such
a conclusion, since UV-visible absorption
spectra were performed with a double-
beam spectrophotometer using drug
samples and reference controls, having
exactly the same ethanol concentration.
Subsequently the commentary claims that
“the authors tested a complex mixture
of G. sempervirens extract, containing at
least about 0.154mM EtOH at 2c, if dilu-
tions were conducted exactly” and that
“concentration of EtOH, set at 30% v/v,
faded out to 0.003% in tested dilutions but
the authors did not clarify how much for
each centesimal dilution in the Methods
section.” The writer supposes that high
ethanol concentration could have caused
“latent apoptosis.” This is confusing and
misleading. As clearly indicated in our
paper (Marzotto et al., 2014), the final
ethanol concentration was 0.03% v/v
(p. 2), and “no significant differences in
cell viability were observed between cells
treated with the ethanol control solution
0.03% (v/v) and untreated cells” (p. 5).
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Furthermore, as other researchers have
found (Do et al., 2013), cell viability
of neurocytes is unaffected by doses of
ethanol up to 10mmol/L (0.06%). Low
doses of ethanol may influence gene
expression, but would have acted in the
same way in the Gelsemium and in the
control samples. To rule out any mis-
interpretation of our findings, Figure 1
gives a brief outline of our microarray
experiments.
Finally, the commentary (Chirumbolo,
2014)maintains that “Gene array profile of
expression following 24 h incubation with
Gelsemium 2c, showed down-regulation
of 49 genes, namely 87.5% gene array.”
It is hard to understand how this 87.5%
of genes was calculated, since the 49
genes represent about 0.1% of the genes
on the microarray chip. The observa-
tion that “many gene products, listed
in the expression profile of 56 genes
array, such as LOC154872, KIAA0825,
LOC150763, C1orf167, have not been
identified” is bizarre. The presence of some
as yet unidentified sequences in the human
genome database is of course well known.
We hope that these clarifications will
be welcomed in the interests of provid-
ing correct and truthful information to
readers. In summary, we provided reli-
able evidence that Gelsemium exerts a
prevalently inhibitory effect on a series
of neurocyte genes across a wide dose
range (Marzotto et al., 2014; Olioso et al.,
2014). The effect decreases with decreas-
ing doses, but whole genome expres-
sion analysis made it possible to detect
statistically significant changes even at
extremely low doses and homeopathic
dilutions (e.g., 5th and 9th centesimal
dilution, corresponding to final gelsem-
ine concentrations of 6.5× 10−15 mol/L
and 6.5× 10−23 mol/L respectively). More
robust conclusions about the role of
the genes involved will require deter-
mination whether proteins encoded by
the affected genes are similarly changed,
using proteomic and phosphoproteomic
approaches, and/or further studies using
purified active plant compounds.
FIGURE 1 | Workflow of the main steps of the DNA-microarray
experiments aimed to discover differentially expressed genes in
Gelsemium-treated neuronal cells compared with control treated cells.
Cultured SHSY5Y cells were incubated for 24 h with the Gelsemium dilutions
/dynamizations or the corresponding control, both treated with the same
ethanol final concentration of 0.03% v/v (A). After the treatment the RNA
content was extracted from the cells, cDNA synthesized (B) and hybridized
on Human Expression microarray (C). In every subarray of the chip, each
transcript was targeted with three separate probes, merging the
fluorescence values and attributing a statistical score. Four independent
replicate experiments were conducted (D). Bioinformatic and statistical
analysis of microarray data provided the final results (E). Differentially
expressed genes were identified on the 45033 cases using Limma test
adjusted for the False Discovery Rate cases using the Benjamini and
Hochberg method. Fold change was calculated as Log2-transformed
fluorescence value of Gelsemium dilutions minus Log2-transformed
fluorescence value of the mean of controls. Various Gelsemium dilutions
were compared with their respective controls using the Friedman test
followed by Fisher’s exact test. All cultures and tests were performed in
sterile conditions using apyrogenic materials and solutions.
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